Literature DB >> 19684413

Cortactin interacts with podocalyxin and mediates morphological change of podocytes through its phosphorylation.

Tatsuo Kobayashi1, Mitsuru Notoya, Toshihiro Shinosaki, Hidetake Kurihara.   

Abstract

BACKGROUND/AIMS: Morphological change of podocytes is closely correlated with the development of proteinuria. Podocalyxin is a major sialoglycoprotein of the podocytes and is thought to be involved in the maintenance of the foot processes structure. Our aim was to examine the mechanism by which podocalyxin contributes to the morphological change of podocytes.
METHODS: We searched protein(s) which coprecipitate with podocalyxin using rat glomerular lysate. Localization of podocalyxin and the coprecipitated protein, cortactin, was studied in a model of puromycin aminonucleoside (PAN) nephrosis by immunocytochemistry. Tyrosine phosphorylation of cortactin was examined. Association of the podocalyxin/cortactin complex with the actin cytoskeleton was evaluated by extraction with Triton-X and immunoblotting.
RESULTS: Cortactin was found to be co-immunoprecipitated with podocalyxin. Immunocytochemical analysis revealed that these 2 proteins colocalized in the apical side of podocytes. In PAN nephrosis, localization of cortactin was altered after the onset of proteinuria, with increased tyrosine phosphorylation. Simultaneously, the dissociation of the podocalyxin/cortactin complex from the actin cytoskeleton was induced.
CONCLUSIONS: These results indicate that cortactin mediates interaction between podocalyxin and actin filaments in podocytes and that alteration of this interaction may play a role in the process of morphological change of podocytes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19684413     DOI: 10.1159/000235245

Source DB:  PubMed          Journal:  Nephron Exp Nephrol        ISSN: 1660-2129


  8 in total

Review 1.  Are podocytes motile?

Authors:  Nicole Endlich; Florian Siegerist; Karlhans Endlich
Journal:  Pflugers Arch       Date:  2017-06-24       Impact factor: 3.657

2.  Sirtuin1 Maintains Actin Cytoskeleton by Deacetylation of Cortactin in Injured Podocytes.

Authors:  Shuta Motonishi; Masaomi Nangaku; Takehiko Wada; Yu Ishimoto; Takamoto Ohse; Taiji Matsusaka; Naoto Kubota; Akira Shimizu; Takashi Kadowaki; Kazuyuki Tobe; Reiko Inagi
Journal:  J Am Soc Nephrol       Date:  2014-11-25       Impact factor: 10.121

3.  Primary cilia disappear in rat podocytes during glomerular development.

Authors:  Koichiro Ichimura; Hidetake Kurihara; Tatsuo Sakai
Journal:  Cell Tissue Res       Date:  2010-05-22       Impact factor: 5.249

4.  A comparative analysis of glomerulus development in the pronephros of medaka and zebrafish.

Authors:  Koichiro Ichimura; Ekaterina Bubenshchikova; Rebecca Powell; Yayoi Fukuyo; Tomomi Nakamura; Uyen Tran; Shoji Oda; Minoru Tanaka; Oliver Wessely; Hidetake Kurihara; Tatsuo Sakai; Tomoko Obara
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

5.  Requirement of podocalyxin in TGF-beta induced epithelial mesenchymal transition.

Authors:  Xiaobo Meng; Peyman Ezzati; John A Wilkins
Journal:  PLoS One       Date:  2011-04-12       Impact factor: 3.240

6.  Podocalyxin regulates pronephric glomerular development in zebrafish.

Authors:  Koichiro Ichimura; Rebecca Powell; Tomomi Nakamura; Hidetake Kurihara; Tatsuo Sakai; Tomoko Obara
Journal:  Physiol Rep       Date:  2013-08

7.  Subfractionation, characterization, and in-depth proteomic analysis of glomerular membrane vesicles in human urine.

Authors:  Marie C Hogan; Kenneth L Johnson; Roman M Zenka; M Cristine Charlesworth; Benjamin J Madden; Doug W Mahoney; Ann L Oberg; Bing Q Huang; Alexey A Leontovich; Lisa L Nesbitt; Jason L Bakeberg; Daniel J McCormick; H Robert Bergen; Christopher J Ward
Journal:  Kidney Int       Date:  2013-11-06       Impact factor: 10.612

8.  Podocalyxin promotes proliferation and survival in mature B-cell non-Hodgkin lymphoma cells.

Authors:  Estíbaliz Tamayo-Orbegozo; Laura Amo; Marta Riñón; Naiara Nieto; Elena Amutio; Natalia Maruri; Miren Solaun; Arantza Arrieta; Susana Larrucea
Journal:  Oncotarget       Date:  2017-09-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.